Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_4534_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Contents
- •1.1.9 Laryngeal Atresia
- •1.1.10 Laryngeal Webs
- •1.1.11 Congenital Subglottic Stenosis
- •1.1.12 Laryngeal Cleft
- •1.1.13 Tracheoesophageal Fistula
- •1.1.14 Tracheal Bronchus
- •1.2.2 Mesenchyme Development
- •1.2.4 Lung Development
- •1.2.4.1 Embryonic Stage
- •1.2.4.2 Pseudoglandular Stage
- •1.1.1 Oral Cavity
- •1.1.2 Nasal Cavity
- •1.1.3 Palate
- •1.1.4 Primitive Pharynx
- •1.1.5 Upper Airway Anomalies
- •1.1.6 Cleft Lip/Palate
- •1.1.7 Choanal Atresia
- •1.1.8 Laryngomalacia
- •1.2.4.3 Canalicular Stage
- •1.2.4.4 Saccular Stage
- •1.2.4.5 Alveolar Stage
- •1.2.5 Congenital Respiratory System Defects
- •1.2.5.1 Tracheal Agenesis
- •1.2.5.2 Congenital Tracheal Stenosis
- •1.2.5.3 Lung Agenesis
- •1.2.5.4 Lung Hypoplasia
- •References
- •2.1 Introduction
- •2.2 Nasal Cavity
- •2.2.1 Vestibule
- •2.2.2 Respiratory Mucosa
- •2.2.3 Olfactory Mucosa
- •Supporting Cells
- •Basal Cell
- •Olfactory Receptor Cell (Bipolar Neuron)
- •Brush Cell (Microvillar Cell)
- •2.2.3.2 The Lamina Propria
- •2.2.3.3 Olfactory Glands (Bowman’s Glands)
- •2.3 Paranasal Sinuses
- •2.4 Pharynx
- •2.5 Larynx
- •2.6 Trachea
- •2.6.1.1 Ciliated Columnar Cells
- •2.6.1.2 Goblet Cells
- •2.6.1.3 Brush Cells
- •2.6.1.4 Basal Cells
- •2.6.1.5 Enteroendocrine System Cells (Kulchitsky Cells or DNES Cells)
- •2.6.2 Lamina Propria
- •2.7 Lungs
- •2.7.1 Pleura
- •2.7.2 Bronchi
- •2.7.3 Bronchioles
- •2.7.3.1 Terminal Bronchioles
- •2.7.3.2 Respiratory Bronchioles
- •2.7.4 Ductus Alveolaris
- •2.7.5 Alveoli
- •2.7.5.2 Type II Alveolar Cell (Septal Cell, Large Alveolar Cell)
- •References
- •3.1.1.3 Nerves
- •Ophthalmic Division
- •Maxillary Division
- •Parasympathetic Nerve Supply
- •3.1.1.4 Bony Anatomy
- •3.1.1.5 Cartilaginous Pyramid
- •3.1.1.6 Structure
- •External Nasal Anatomy
- •Internal Nasal Anatomy
- •3.1.2 Nasal Physiology
- •3.1.2.1 Nasal Airflow
- •3.1.2.2 Abnormal Nasal Physiology
- •3.2.1 Larynx Anatomy
- •Cricoid Cartilage
- •Thyroid Cartilage
- •Epiglottis
- •Arytenoid Cartilages
- •Corniculate Cartilages
- •Cuneiform Cartilages
- •Extrinsic Ligaments
- •Intrinsic Ligaments
- •Laryngeal Cavity
- •Piriform Recesses
- •Cricothyroid Muscles
- •Posterior Cricoarytenoid Muscles
- •Lateral Cricoarytenoid Muscles
- •Transverse Arytenoid Muscle
- •Thyroarytenoid Muscles
- •Superior Laryngeal Nerve
- •Arteries
- •Veins
- •Lymphatics
- •Swallowing
- •Respiration
- •Phonation
- •3.2.2.1 Reflex Glottic Closure
- •References
- •4.1 Introduction
- •4.2.1 Choanal Atresia
- •4.2.2 Pyriform Aperture Stenosis
- •4.2.3 Cleft Lip Nasal Deformity
- •4.2.4 Nasolacrimal Duct Cysts
- •4.2.5 Encephaloceles
- •4.3 Craniofacial Anomalies
- •4.3.1 Pierre Robin Syndrome
- •4.3.2 Treacher-Collins Syndrome
- •4.3.3 Crouzon Syndrome
- •4.3.4 Down Syndrome
- •4.3.5 Apert Syndrome
- •4.4.1 Thyroglossal Duct Cyst
- •4.4.2 Laryngomalacia
- •4.4.3 Vocal Fold Paralysis
- •4.4.5 Subglottic Stenosis
- •4.4.6 Subglottic Hemangioma
- •4.4.7 Laryngeal Cysts
- •4.4.8 Laryngeal Cleft
- •4.5 Conclusion
- •References
- •5.1 Innate Immunity
- •5.2 Adaptive Immunity
- •References
- •6.1 Introduction
- •6.2 Innate Immunity
- •6.3 Adaptive Immunity
- •References
- •7.1 Introduction
- •References
- •8: Respiratory Microbiome
- •8.1 Introduction
- •8.2.1 Childhood Asthma
- •8.2.2 Asthma Exacerbation
- •8.3 Bacteriome
- •8.4 Virome
- •8.5 Mycobiome
- •References
- •9.1 Introduction
- •References
- •10.1 Introduction
- •10.3.3 The Appointment Process, Explained
- •10.3.5 Parental Involvement
- •10.4 Coordinating Care When Your Child Is Ill
- •10.4.3 Exhibit Cohesion
- •10.6 Conclusion
- •References
- •11.1 Introduction
- •11.2 Nasal Cavity
- •11.2.1 Choanal Atresia
- •11.2.2 Rhinosinusitis
- •11.2.4 Juvenile Nasopharyngeal Angiofibroma
- •11.3 Pharynx
- •11.4 Nasopharynx
- •11.4.1 Adenoid Hypertrophy
- •11.4.2 Nasopharyngeal Carcinoma
- •11.5 Oropharynx
- •11.5.1 Thyroglossal Duct Cyst
- •11.6 Hypopharynx
- •11.6.1 Retropharyngeal Abscess
- •11.6.2 Lymphatic Malformation
- •11.6.4 Lymphoma
- •11.6.5 Rhabdomyosarcoma
- •11.7 Larynx
- •11.7.1 Subglottic Stenosis
- •11.7.2 Laryngotracheal Papillomatozis
- •11.7.3 Croup
- •11.7.4 Epiglottitis
- •11.7.5 Foreign Body Aspiration
- •References
- •12.2.1 Plain Radiography
- •12.2.1.1 The Thymus
- •Tracheal Buckling
- •Hilum
- •Diaphragm
- •Mediastinal Borders
- •Lung Opacities
- •Cystic Lung Diseases
- •Pulmonary İnterstitial Emphysema (PIE)
- •Unilateral Hyperlucent Lung
- •12.2.2 Fluoroscopy
- •12.2.3 Ultrasound
- •12.2.4 Computed Tomography
- •12.2.5 Magnetic Resonance Imaging (MRI)
- •12.2.6 Angiography
- •12.2.7 Positron Emission Tomography (PET)
- •12.3 Conclusion
- •References
- •13.1 Introduction
- •13.2 Nasal Diagnostic Procedures
- •13.2.1 Indications
- •13.2.2 Contraindications
- •13.2.3 Anatomical Features
- •13.2.4 Technical Considerations
- •13.2.5 Technique
- •13.2.5.1 First Pass
- •13.2.5.2 Second Pass
- •13.2.5.3 Third Pass
- •13.3 Flexible Laryngoscopy
- •13.4 Direct Laryngoscopy
- •13.5 Video Laryngoscopy
- •13.5.1 Indications
- •13.5.2 Contraindications
- •13.5.3 Outcomes
- •13.5.4 Equipment
- •13.5.5 Approach Considerations
- •References
- •14.1 Upper Airways
- •14.2.3 Laryngeal Pathologıes
- •References
- •15.1 Introduction
- •15.2 Airway Measurements
- •References
- •16.1 Introduction
- •16.2 Background
- •References
- •17: Allergen Testing: Purpose, Procedure, Interpretation
- •17.1 Introduction
- •17.2 Tests
- •17.2.1 Skin Tests
- •17.2.3 Component Resolved Diagnosis (CRD)
- •17.2.4 Tryptase
- •17.2.5 Basophil Activation Test (BAT)
- •17.2.6 Provocation Tests
- •17.2.7 Nasal sIgE
- •17.2.8 Nasal Smear Eosinophilia
- •17.2.9 Eosinophilic Cationic Protein (ECP)
- •References
- •18: Smell Testing: Purpose, Procedure, Interpretation
- •18.1 Introduction
- •18.2 Possible Olfactory Disorder Diagnosis
- •18.2.1 Conductive Defects
- •18.2.3 Inherited Disorders
- •18.2.3.1 Hormonal Disturbances
- •18.4 Odor Threshold Tests
- •18.8.1 Butanol Threshold Test
- •18.8.1.1 The Penn State University Odor Identification Exam
- •18.8.2 Cross-Cultural Smell Identification Test
- •18.8.3 Sniffin’ Sticks
- •References
- •19: Taste Testing: Purpose, Procedure, Interpretation
- •19.1 Introduction
- •19.2 Definitions
- •19.2.1 Taste Dysfunction Abnormalities
- •19.4.1 Taste Dysfunction
- •19.4.2 COVID-19
- •19.5 Taste Disorder Diagnosis
- •19.6.2 Magnitude Matching
- •19.6.3 Spatial Test
- •References
- •20.1 Introduction
- •20.2 Primary Otalgia Causes
- •20.2.1 Auricle
- •20.2.1.1 Infections
- •20.2.1.2 Trauma
- •20.2.1.3 Allergic Angioedema
- •20.2.1.4 Thermal Damage
- •20.2.2 External Auditory Canal
- •20.2.2.1 Otitis Externa
- •20.2.2.2 Malignant Otitis Externa
- •20.2.2.3 Eczematous Dermatitis
- •20.2.2.4 Furunculosis
- •20.2.2.5 Foreign Body
- •20.2.2.6 Cerumen Impaction
- •20.2.2.7 Tumors
- •20.2.3 Middle Ear
- •20.2.3.1 Acute Otitis Media
- •20.2.3.3 Eustachian Tube Dysfunction
- •20.2.3.4 Cholesteatoma
- •20.2.3.5 Trauma
- •20.3 Secondary Otalgia Causes
- •20.3.1 Oropharyngeal Infections
- •20.3.2 Dental Causes
- •20.3.3 Auricular Lymphadenitis
- •20.3.4 Neck Abscess
- •20.3.5 Parotitis
- •20.3.6 Temporomandibular Joint Dysfunction
- •20.3.7 Sinusitis
- •20.4 Differential Diagnosis
- •References
- •21.1 Introduction
- •21.2 Bacterial Otitis Externa
- •21.3 Acute Otitis Media
- •21.4 Chronic Suppurative Otitis Media
- •21.5 Foreign Body
- •21.5.1 Cerumen
- •21.5.2 Tympanostomy Tube Drainage
- •21.5.3 Traumatic Cerebrospinal Fluid Otorrhea
- •21.5.5 Necrotizing Otitis Externa (Malignant External Otitis)
- •21.5.6 Neoplasms
- •21.5.7 Polyps
- •21.5.8 Otomycosis
- •21.5.9 First Branchial Cleft Cysts
- •21.5.10 Cholesteatoma
- •21.5.11 Spontaneous Cerebral Spinal Fluid Otorrhea
- •References
- •22.1 Introduction
- •22.4 Congenital Causes
- •22.4.1 Choanal Atresia
- •22.4.2 Pyriform Apertura Stenosis
- •22.4.3 Nasal Midline Congenital Masses
- •22.4.3.1 Nasal Dermoid Cyst
- •22.4.3.2 Nasal Glioma
- •22.4.3.3 Encephalocele (Encephalo-Meningocele)
- •Differential Diagnosis
- •22.4.3.4 Nasolacrimal Duct Cyst (Dacryocystocele)
- •22.5 Infectious Causes
- •22.5.1.1 Rhinitis Etiology
- •22.5.2 Neonatal Rhinitis
- •22.5.3 Bacterial or Viral Rhinitis
- •22.5.4 Iatrogenic Rhinitis
- •22.5.5 Infectious Rhinitis (Rhinosinusitis)
- •22.6 Adenoid Hypertrophy
- •22.7 Inflammatory Causes
- •22.7.1 Allergic Rhinitis
- •22.7.2 Nonallergic Rhinitis
- •22.7.3 Eosinophilic Nonallergic Rhinitis (NARES)
- •22.7.4 Nasal Polyp
- •22.7.5 Antrochoanal Polyp
- •22.7.6 Inferior Turbinate Hypertrophy
- •22.8 Neoplasia
- •22.8.1 Benign Tumors (Juvenile Nasopharyngeal Angiofibroma)
- •22.8.2 Malignant Tumors
- •22.9 Systemic Causes
- •22.9.1 Cystic Fibrosis
- •22.9.2 Primary Ciliary Dyskinesia
- •22.10 Trauma/Iatrogenic Causes
- •22.10.1 Nasal Trauma-Septal Hematoma
- •22.10.2 Septum Deviation
- •22.10.3 Nasal Foreign Bodies
- •References
- •23.1 Introduction
- •23.2 Pathophysiology
- •23.3 Allergic Rhinitis
- •23.4 Non-allergic Rhinitis
- •23.5 Infectious Rhinitis
- •23.6.1 Vasomotor Rhinitis
- •23.7 Evaluation
- •23.8 Diagnosis
- •23.9 Treatment
- •23.10 Prognosis
- •23.11 Conclusion
- •References
- •24.1 Introduction
- •24.2 Pathogenesis
- •24.3 Diagnosis
- •24.3.1 History
- •24.3.2 Examination
- •24.4 Differential Diagnoses
- •24.5 CSF Rhinorrhea
- •24.5.1 CSF Physiology
- •24.5.1.1 Pathogenesis
- •24.6 Diagnosis
- •24.6.1 Chemical Diagnosis
- •24.6.2 Imaging Diagnosis
- •24.7 Treatment
- •24.7.1 Surgical Technique
- •References
- •25.1 Introduction
- •25.1.1 Waldeyer Ring
- •25.3 Anatomy
- •25.3.1 Lymphatic Drainage
- •25.3.1.1 Nerve Supply
- •25.6 Tonsillary Hypertrophy
- •25.7 Physical Examination
- •25.8.1 Obstructive Sleep Apnea
- •References
- •26.1 Introduction
- •26.5 Halitosis Physiopathology
- •26.6.1 Oral Halitosis (Intraoral Halitosis, Oral Malodor)
- •26.6.1.1 Periodontal Infections
- •26.6.1.2 Tongue Oriented Halitosis
- •26.6.1.3 Peritonsillar Abscess
- •26.7 Paranasal Sinus Diseases
- •26.8 Adenoid Vegetation
- •26.9 Chronic Pharyngitis
- •26.10 Chronic Tonsillitis
- •26.11 Tonsillolith
- •26.12 Non-Oral Halitosis
- •26.13 Gastroesophageal Reflux
- •26.14 Diagnosis
- •26.14.1 Organoleptic Measurement
- •26.14.2 Sulfur Monitoring
- •26.14.2.1 Indirect Methods
- •26.14.2.3 Ammonia Monitoring
- •26.14.2.4 Polymerase Chain Reaction (PCR)
- •26.15 Physical Examination
- •References
- •27.1 Introduction
- •27.2 Epidemiology
- •27.4 Diagnosis
- •27.5.1 Clinical Assessment
- •27.6 Treatment
- •27.6.1 Voice Therapy
- •27.7 Phonosurgery
- •References
- •28.1 Introduction
- •28.2 Epidemiologic Characteristics
- •28.3 Swallowing Physiologic Phases
- •28.3.1.1 Prematurity
- •28.3.1.2 Neuromuscular
- •28.3.1.5 Cardiopulmonary Disease
- •28.4 Symptoms
- •28.5 Clinical Feeding Assessment
- •28.7 Flexible Endoscopic Swallowing Evaluation
- •28.8 Imaging
- •28.9 Endoscopic Assessments
- •28.9.1 High-Resolution Manometry
- •28.10 Medical Management
- •28.11 Surgical Management
- •28.11.1 Ankyloglossia
- •28.11.2 Laryngomalacia
- •28.11.3 Laryngeal Cleft
- •28.12 Conclusions
- •References
- •29.1 Introduction
- •29.2 Reactive Lymph Node Enlargements
- •29.3 Vaccines
- •29.4 Acute Suppurative Lymphadenitis
- •29.6 Granulomatous Lymphadenitis
- •29.6.1 Mycobacterial Infection
- •29.6.2 BCG Vaccine
- •29.6.3 Cat-Scratch Disease
- •29.6.4 Sarcoidosis
- •29.6.5 Kikuchi-Fujimoto Disease
- •29.7 Malignancies
- •29.8 Diagnosis
- •References
- •30.1 Introduction
- •30.2 Upper Airway Cough Syndrome
- •30.3 Chronic Rhinosinusitis
- •30.5 Otogenic Cough
- •30.6 Laryngeal Clefts
- •30.7 Conclusion
- •References
- •31.1 Introduction
- •31.5.1 Vocal Cord Disfunction (VCD)
- •31.5.2 Obstructive Sleep Apnea Syndrome (OSAS)
- •31.5.3 Allergic or Non-Allergic Rhinitis
- •31.6 Conclusion
- •References
- •32.1 Introduction
- •32.2.1 Non-massive Hemoptysis
- •32.2.2 Massive Hemoptysis
- •32.4 Diagnostic Evaluation
- •32.4.1 History
- •32.4.1.1 Infection Warning Signs
- •32.4.1.2 Choking
- •32.4.1.3 Exposures
- •32.4.1.4 Underlying Medical Problems
- •32.4.2 Physical Examination
- •32.4.3 Laboratory Evaluation
- •32.4.4 Imaging
- •32.5.1 Respiratory Illness
- •32.5.3 Trauma
- •32.5.4 Hemoptysis Mimics
- •References
- •33.1 Introduction
- •33.6 Conclusion
- •References
- •34: Pediatric Allergic Rhinitis: Otolaryngology Perspective
- •34.1 Introduction
- •34.2 Epidemiology
- •34.2.1 Prevalence
- •34.2.2 Risk factors
- •34.3.1 Classical Pathway
- •34.3.2 Nasal Pathway
- •34.4.2 Physical Examination
- •34.4.3 Diagnostic Tests
- •34.4.4 Nasal Cytology
- •34.4.5 Imaging
- •34.5.1 Adenoid Hypertrophy
- •34.5.2 Nasal Septal Deviation
- •34.5.3 Chronic Rhinosinusitis
- •34.5.4 Turbinate Hypertrophy
- •34.5.5 Nasal Foreign Body
- •34.5.6 Other Clinical Conditions
- •34.6.1 Saline Irrigation (Douching)
- •34.7 Treatment
- •34.7.1 Oral Antihistamines
- •34.7.2 Intranasal Steroids
- •34.7.3 Leukotriene Inhibitors
- •34.7.5 Oral Steroids
- •34.7.6 Intranasal Antihistamines
- •34.7.7 Immunotherapy (Sublingual-Subcutaneous)
- •34.8 Conclusion
- •References
- •35: Allergic Rhinitis: Pediatric Pulmonologist Perspective
- •35.1 Introduction
- •35.2.1 Epidemiological Relationship
- •35.2.4 Immunopathology
- •35.2.7 Non-pharmaceutical Treatment Method
- •35.2.8 Pharmaceutical Medication Policy
- •35.2.9 Immunotherapy Against Allergens
- •35.6 Conclusion
- •References
- •References
- •37.1 Introduction
- •37.2 Adenoid Hypertrophy
- •37.7 Preoperative Evaluation
- •37.8 Contraindications
- •37.9 Complications
- •37.9.1 Bleeding
- •37.9.2 Hypernasality
- •37.9.3 Surgical Traumas
- •37.9.4 Torticollis
- •37.9.5 Otitis Media
- •37.9.6 Psychological Trauma
- •37.9.7 Nasopharyngeal Stenosis
- •37.9.8 Recurrence
- •37.10 Postoperative Care
- •37.11 Surgery
- •37.12.1 Adenoiditis
- •References
- •38.1 Introduction
- •38.2 Anatomy
- •38.2.1 Palatine Tonsils (Faucial Tonsils)
- •38.2.2 Lingual Tonsil
- •38.2.3 Adenoids (Pharyngeal Tonsil)
- •38.2.4 Tubal Tonsils
- •38.5.1 Viral Tonsillitis
- •38.5.2 Bacterial Tonsillitis
- •38.5.3 Candida
- •38.6.1 Suppurative Complications
- •38.6.1.1 Peritonsillar Abscess (Quincy Tonsil)
- •Lemierre’s Syndrome
- •38.6.2 Nonsuppurative Complications
- •38.6.2.1 Acute Rheumatic Fever
- •38.6.2.2 Poststreptococcal Glomerulonephritis
- •38.6.2.3 Scarlet Fever
- •38.6.2.6 Palmoplantar Pustulosis (PPP)
- •38.6.2.7 IgA Nephropathy
- •38.7 Clinical Manifestation
- •38.7.1 Infection
- •38.7.2 Obstruction
- •38.7.3 Neoplasia
- •38.8 Diagnosis
- •38.8.2 Physical Examination
- •38.8.3 Laboratory
- •38.8.4 Imagining
- •38.8.5 Polysomnography
- •38.9 Treatments
- •38.9.1 Medical Treatment
- •38.9.2 Surgery
- •38.9.2.2 Tonsillectomy
- •38.9.3.1 Intraoperative Complications
- •38.9.3.4 Postoperative Long-Term Complications (>weeks)

33 Airway Inammation: United Airway inChildren
431
33.2 Pathophysiologic Mechanisms Underlying
theRelationship Between Rhinitis/Rhinosinusitis
andAsthma
Local Mechanisms (1, 2, 3): Over the years, several local and systemic mechanisms explaining the interaction between the upper and lower airways have been
proposed [1, 2, 4, 6]. These are summarized in Fig.33.1. Mouth Breathing (1):
In individuals with rhinitis/rhinosinusitis, the nose may be obstructed, and mouth
breathing is favored, thereby eliminating this vital upper airway defense mechanism. This abnormal breathing (excluding the passage of air through the sinus
system and the loss of function of inamed/infected sinuses) compromises air
warming, humidication, and purication from pollutants and irritants, allowing
physical and chemical agents to have an impact on the lower airways [2, 6]. In
addition, the impairment of air ltering in the presence of sinus disease may
increase allergen load reaching the bronchi in allergic patients. Baraldi etal. have
proposed a novel and intriguing pathogenetic hypothesis that nitric oxide, which
is thought to have a modulating effect on bronchial tone and is an important hostdefense molecule, is decreased during sinusitis, and that decreased physiologic
autoinhalation may play a role in increasing bronchial reactivity and susceptibility to infection [2, 6]. Aspiration of Nasal Contents (2): The concept that inammatory secretions from the upper airway of patients with rhinitis or rhinosinusitis
are aspirated into the lower airway with negative consequences has traditionally
been regarded as one of the primary mechanisms underlying lower airway symptoms. The few available studies, however, have not conclusively supported this
hypothesis [2, 9]. Neural Reexes (3): The presence and signicance of a sinonasal-bronchial reex, characterized by bronchoconstriction triggered by the activation of a trigeminal afferent-vagal efferent neural pathway, remains a topic of
debate in human studies, despite being extensively documented in animal models
[6, 9]. Rolla etal. demonstrated that damage to the pharyngeal mucosa in patients
with CRS (likely mediated by the drainage of inammatory mediators and cells
and/or infected material) increased the sub-mucosal nerve’s exposure to irritants,
thereby activating the reex arc [10].
Systemic (Immunological) Mechanisms (4): A large body of evidence suggests that allergic inammation developing in the respiratory mucosa (due to
allergen and/or other irritant agent exposure) may result in systemic inammatory events and that the nose and bronchi are linked through the systemic circulation. The inammatory process in the airways is strengthened and spread
beyond its initial site by the release of immune cells and mediators from the
bone marrow and other lymphoid organs. Despite the potential variability in the
underlying causes, it is widely believed that the primary factor responsible for
immune-mediated inammatory mechanisms in both the upper and lower airways is the presence of widespread eosinophilic inltration of the inamed
mucosa, which is attributed to a prevalent Th2 immune response [3, 4, 6]
(Fig.33.1).

432
Fig. 33.1 Overview of the
complex interplay between
immunological (systemic)
and local mechanisms
(post-nasal drip, neural
reexes, mouth breathing)
in patients with asthma and
rhinosinusitis, according to
the United Airway Disease
theory (*: prevalent
inammation endotype)
M. Serbes et al.
33.3 Phenoendotypes ofUnited Airway Disease Based
onInflammation
The archetype of UAD is allergic asthma-allergic rhinitis, but emerging evidence
suggests that UAD is a heterogeneous condition with multiple phenotypes (observable clinical characteristics) and endotypes (pathobiological mechanisms). To
improve outcomes in the classication and management of UAD, currently known
phenoendotypes of UAD are proposed, in which pathophysiological mechanisms
and biomarkers related to disease are identied and targeted for treatment
(Table33.2) [8, 11].

33 Airway Inammation: United Airway inChildren
Table 33.2 Phenoendotypes of united airway disease (UAD) based on airway inammation type
Inammation
type Endotype
Eosinophilic,
Th2-high type
Allergic,
systemic
Allergic, local IgE-mediated Local allergic
Non-allergic
eosinophilic
Neutrophilic,
Th2-low type
CRSwNP chronic rhinosinusitis with nasal polyps, CRSsNP chronic rhinosinusitis without nasal
polyps, FENO fractional exhaled nitric oxide, TSLP thymic stromal lymphopoietin, COPD chronic
obstructive pulmonary disease
a
Serum normal periostin level is 10ng·mL−1; a higher level identies an inammatory status.
Blood and sputum eosinophil count of >2% or >300 cells/uL identies airway eosinophilia (blood
eosinophil count <150 cells/uL indicates low likelihood of airway eosinophilia), sputum neutrophil count ≥65% or >500 cells/104mL identies airway neutrophilia (cut-off <40% indicates low
likelihood of airway neutrophilia). A FENO value <25 ppb (<20 ppb in children) is considered
normal, while levels >50ppb (>35ppb in children) are indicative of eosinophilic inammation.
Elevated serum total IgE levels (IgE >30 and <1500IU/mL) and positive specic IgE to at least
one aeroallergen identify allergic inammation in children (age ≥6years) [8, 11, 12]
Th2, IL-4,
IL-5, IL-13
IgE-mediated Allergic
IL-25, IL-33,
TSLP, group
2 innate
lymphoid
cells (ILC2)
Th1, Th17,
IL-17
Clinical phenotype
Lower airway Upper airway
CRSwNP Eosinophilic
asthma
Allergic
rhinitis
rhinitis
Non-allergic
rhinitis with
eosinophilia
CRsNP,
İnfectious
rhinitis
asthma
Intrinsic
asthma
Adult-onset
eosinophilic
asthma
Neutrophilic
asthma,
COPD
Assessment method/
biomarker
Blood periostin, high
FENO, sputum, and
blood eosinophilia
Blood total IgE and
specic IgE, skin prick
tests
Local nasal and
bronchial mucosaspecic IgE
Blood periostin, high
FENO, sputum, and
blood eosinophilia
Blood IL-8 and IL-17,
sputum neutrophilia
a
433
33.4 Pathways ofAirway Inflammation inUnited
Airway Disease
The role of airway inammation in the development of UAD is signicant and is
frequently triggered by the activation of the airway epithelium due to various
environmental factors such as microbes (including respiratory viruses and bacteria), pollutants, and allergens. It is a dynamic trait that changes over time and is
inuenced by factors such as treatment, infection, environmental exposures, and
disease progression [12, 13]. The identication of the pathways of airway inammation, which encompass intricate, interconnected, and overlapping cascades
regulated by various proinammatory cytokines, has yielded crucial and transformative knowledge regarding the specic endophenotypes of UAD [1, 11, 12]. To
date, airway inammation in the upper and lower airways is classied into 2 specic molecular pathways called Th2-high type (eosinophilic) and Th2-low type
(neutrophilic).

434
M. Serbes et al.
Th2-high inammation is caused by both the adaptive and innate immune systems
and contributes to the pathophysiology of several chronic upper and lower airway diseases, including asthma, COPD, CRSwNP, and allergic rhinitis [11, 14]. Th2 cells and
group 2 innate lymphoid cells (ILC2) drive type 2 inammation by producing type 2
cytokines such as interleukin (IL)-4, IL-5, and IL-13, as well as other inammatory
mediators [11, 14]. In the pathophysiology of type 2 inammatory airway diseases, type
2 cytokines play a variety of roles. IL-5 is essential for the differentiation, maturation,
mobilization, and survival of IL-5R+ eosinophil progenitors in the bone marrow.
Furthermore, IL-5 promotes the development of other type 2 cells, which include mast
cells and basophils [15]. Both IL-4 and IL-13 are involved in B-cell class switching and
IgE production, which results in basophil and mast cell degranulation and the release of
proinammatory mediators, as well as barrier disruption and tissue remodeling [7, 11,
16]. Goblet-cell hyperplasia, mucus production, smooth muscle contractility, and hyper-
plasia are all impacted by IL-13 [11, 16]. Additionally, the development of mucus plugs
as a result of mucus production is linked to IL-13-mediated damage to the epithelial
barriers [17]. The trafcking of eosinophils to tissues is mediated by IL-4, IL-13, and
IL-5 [11, 14–16]. Clinical symptoms of these common pathophysiological effects,
which are caused by type 2 inammation, include nasal polyps, loss of smell, nasal
obstruction in allergic rhinitis and CRSwNP [18, 19], impaired lung function, wheezing,
shortness of breath, chest tightness, and coughing in asthma [20]. Interleukin-5- and
interleukin-13-producing group 2 innate lymphoid cells (ILC2s) have been identied as
a novel subset of lymphocytes. These cells possess the ability to induce eosinophilic
inammation independently of adaptive immunity, including Th2 cells, B cells, and IgE
antibodies. ILC2s are stimulated by cytokines IL-25, IL-33, and thymic stromal lymphopoietin (TSLP) that are derived from epithelial cells. These cytokines are released by
epithelial cells in response to damage caused by various stimuli such as microbiota and
pollutants [11, 14–16]. The corresponding phenoendotype in upper airways has been
termed non-allergic rhinitis with eosinophilia syndrome (NARES) while termed nonallergic eosinophilic asthma in the lower airways in UAD (Table33.2).
Th2-low inammation is mainly characterized by neutrophils in nasal and bronchial mucosa [5, 21, 22]. Infections or chronic irritation, such as air pollution, can cause
neutrophilic inammation. This causes innate immune system dysregulation and activation of the IL-17 pathway, as well as neutrophil recruitment to the nasal and bronchial
mucosa, which is known to be mediated by IL-8 [21, 22]. Furthermore, it has been
observed that the type 1 immune response, metabolic and epigenetic factors, as well as
the activation of the epithelial-mesenchymal trophic unit, can contribute to signicant
remodeling processes in the absence of inammation. These factors have been recognized as inuential elements in modulating neutrophilic inammation [22, 23].
33.5 The Role ofAirway Epithelium inUnited Airway Disease
This knowledge has been augmented by the realization of the signicance of airway epithelium in inammatory processes. The airway epithelium serves as a
protective barrier and environmental sensor to triggers (allergens, pollutants,

33 Airway Inammation: United Airway inChildren
435
smoking, etc.) and is the rst line of defense against insults inhaled. By stimulating innate and adaptive immune reactions, it promotes immunity. After epithelial
damage or immune cell activation, it quickly activates epithelial cells to produce
“upstream” alarmin epithelial cytokines, including IL-25, IL-33, and thymic stromal lymphopoietin (TSLP). These cytokines—TSLP in particular—provide master regulation of Th2 inammation by guiding T-cell maturation along the Th2
cell pathway and triggering the production of downstream Th2 cytokines like
IL-4, IL-5, and IL-13. Through Th1 and Th17, TSLP also contributes to inammation that is Th2-low (neutrophilic). Remodeling of the airways also begins with
the airway epithelium. The direct effects of TSLP on broblasts may aid in the
remodeling of the airways [24, 25].
33.6 Conclusion
Complex, interactive, and redundant cascades of proinammatory cytokines,
including Th2-high, eosinophilic and Th2-low, neutrophilic inammation, mediate
airway inammation in UAD.Consider united airway disease (UAD) in the differential diagnosis for patients presenting with both upper and lower airway inammatory diseases. The research and efforts to better understand the pathophysiology,
identify clinically useful diagnostic markers, and characterize inammatory endotypes will result in more effective targeted therapeutics for individuals presenting
with UAD.
References
1. Bachert C, Luong AU, Gevaert P, et al. The unied airway hypothesis: evidence from
specic intervention with anti-IL-5 biologic therapy. J Allergy Clin Immunol Pract.
2023;11(9):2630–41. S2213-2198(23)00547-0. https://doi.org/10.1016/j.jaip.2023.05.011.
2. de Benedictis FM, Bush A.Janus looks both ways: how do the upper and lower airways interact? Paediatr Respir Rev. 2020;34:59–66. https://doi.org/10.1016/j.prrv.2019.06.004.
3. Ahmad JG, Marino MJ, Luong AU.Unied airway disease: future directions. Otolaryngol Clin
North Am. 2023;56(1):181–95. https://doi.org/10.1016/j.otc.2022.09.014.
4. Poddighe D, Brambilla I, Licari A, Marseglia GL.Pediatric rhinosinusitis and asthma. Respir
Med. 2018;141:94–9. https://doi.org/10.1016/j.rmed.2018.06.016.
5. De Greve G, Hellings PW, Fokkens WJ, Pugin B, Steelant B, Seys SF.Endotype-driven treatment in chronic upper airway diseases. Clin Transl Allergy. 2017;7:22. https://doi.org/10.1186/
s13601- 017- 0157- 8.
6. Kanda A, Kobayashi Y, Asako M, Tomoda K, Kawauchi H, Iwai H.Regulation of interaction
between the upper and lower airways in United Airway disease. Med Sci (Basel). 2019;7(2):27.
https://doi.org/10.3390/medsci7020027.
7. Samitas K, Carter A, Kariyawasam HH, Xanthou G.Upper and lower airway remodelling
mechanisms in asthma, allergic rhinitis and chronic rhinosinusitis: the one airway concept
revisited. Allergy. 2018;73(5):993–1002. https://doi.org/10.1111/all.13373.
8. Yii ACA, Tay TR, Choo XN, Koh MSY, Tee AKH, Wang DY.Precision medicine in united
airways disease: a “treatable traits” approach. Allergy. 2018;73(10):1964–78. https://doi.
org/10.1111/all.13496.

436
9. Lluncor M, Barranco P, Amaya ED, etal. Relationship between upper airway diseases, exhaled
nitric oxide, and bronchial hyperresponsiveness to methacholine. J Asthma. 2019;56(1):53–60.
https://doi.org/10.1080/02770903.2018.1429465.
10. Rolla G, Colagrande P, Scappaticci E, et al. Damage of the pharyngeal mucosa and hyperresponsiveness of airway in sinusitis. J Allergy Clin Immunol. 1997;100(1):52–7. https://doi.
org/10.1016/s0091- 6749(97)70194- 5.
11. Maspero J, Adir Y, Al-Ahmad M, etal. Type 2 inammation in asthma and other airway diseases. ERJ Open Res. 2022;8(3):00576–2021. https://doi.org/10.1183/23120541.00576- 2021.
12. De Filippo M, Votto M, Licari A, etal. Novel therapeutic approaches targeting endotypes of
severe airway disease. Expert Rev Respir Med. 2021;15(10):1303–16. https://doi.org/10.108
0/17476348.2021.1937132.
13. Ricciardolo FLM, Guida G, Bertolini F, Di Stefano A, Carriero V. Phenotype overlap in
the natural history of asthma. Eur Respir Rev. 2023;32(168):220201. https://doi.org/10.118
3/16000617.0201- 2022.
14. Busse WW, Viswanathan R.What has been learned by cytokine targeting of asthma? J Allergy
Clin Immunol. 2022;150(2):235–49. https://doi.org/10.1016/j.jaci.2022.06.010.
15. Kuruvilla ME, Lee FE, Lee GB.Understanding asthma phenotypes, endotypes, and mechanisms of disease. Clin Rev Allergy Immunol. 2019;56(2):219–33. https://doi.org/10.1007/
s12016- 018- 8712- 1.
16. Akdis CA, Arkwright PD, Brüggen MC, etal. Type 2 immunity in the skin and lungs. Allergy.
2020;75(7):1582–605. https://doi.org/10.1111/all.14318.
17. Dunican EM, Elicker BM, Gierada DS, et al. Mucus plugs in patients with asthma linked
to eosinophilia and airow obstruction. J Clin Invest. 2018;128(3):997–1009. https://doi.
org/10.1172/JCI95693.
18. Takabayashi T, Schleimer RP.Formation of nasal polyps: the roles of innate type 2 inammation and deposition of brin. J Allergy Clin Immunol. 2020;145(3):740–50. https://doi.
org/10.1016/j.jaci.2020.01.027.
19. Wise SK, Damask C, Roland LT, etal. International consensus statement on allergy and rhinology: allergic rhinitis—2023. Int Forum Allergy Rhinol. 2023;13(4):293–859. https://doi.
org/10.1002/alr.23090.
20. Manti S, Licari A, Leonardi S, Marseglia GL.Management of asthma exacerbations in the
paediatric population: a systematic review. Eur Respir Rev. 2021;30(161):200367. https://doi.
org/10.1183/16000617.0367- 2020.
21. Robinson D, Humbert M, Buhl R, et al. Revisiting type 2-high and type 2-low airway
inammation in asthma: current knowledge and therapeutic implications. Clin Exp Allergy.
2017;47(2):161–75. https://doi.org/10.1111/cea.12880.
22. Hammad H, Lambrecht BN.The basic immunology of asthma [published correction appears in
Cell. 2021 Apr 29;184(9):2521-2522]. Cell. 2021;184(6):1469–85. https://doi.org/10.1016/j.
cell.2021.02.016.
23. Fang L, Sun Q, Roth M.Immunologic and non-immunologic mechanisms leading to airway
remodeling in asthma. Int J Mol Sci. 2020;21(3):757. https://doi.org/10.3390/ijms21030757.
24. Jakwerth CA, Ordovas-Montanes J, Blank S, Schmidt-Weber CB, Zissler UM.Role of respiratory epithelial cells in allergic diseases. Cells. 2022;11(9):1387. https://doi.org/10.3390/
cells11091387.
25. Frey A, Lunding LP, Ehlers JC, Weckmann M, Zissler UM, Wegmann M.More than just a barrier: the immune functions of the airway epithelium in asthma pathogenesis. Front Immunol.
2020;11:761. https://doi.org/10.3389/mmu.2020.00761.
M. Serbes et al.

Pediatric Allergic Rhinitis: Otolaryngology Perspective
MertCemalGökgöz, CemalCingi,
andGabrielaKopacheva-Barsova
34.1 Introduction
Pediatric nasal obstruction is among the most common reasons for referral to pediatric otolaryngologists [1]. During the neonatal period and infancy, congenital
causes are the most common causes of nasal obstruction, while in the pediatric age
group in advanced ages, allergic, inammatory, and infectious rhinitis come to the
fore as the primary causes [1]. Allergic causes are not considered in the foreground
in nasal congestion in the rst 2years of age, mainly since there is insufcient time
for allergen exposure [2]. The presence of at least two of the complaints of nasal
congestion, rhinorrhea, sneezing, and itching accompanying the inammation of
the nasal epithelium is sufcient for diagnosing rhinitis [3, 4]. Similar complaints
may also occur in the presence of adenoid hypertrophy, acute and chronic sinusitis,
deviation of the septum, or nasal polyp, which are other causes of nasal obstruction
[5]. Allergic rhinitis is the most common chronic disease of childhood and hurts the
quality of life regarding physical, social, and psychological well-being [6]. Allergic
rhinitis leads to impaired sleep, daytime sleepiness, concentration impairment, and
impaired cognitive functions, decreasing school success and impairing the quality
of life for the child and the family. Allergic rhinitis is frequently caused by IgEmediated early and late-phase hypersensitivity response to inhalant allergens [6].
34
M. C. Gökgöz
Department of Otorhinolaryngology, Manisa City Hospital, Manisa, Turkey
C. Cingi (*)
Medical Faculty, Department of Otorhinolaryngology, Eskisehir Osmangazi University,
Eskisehir, Turkey
G. Kopacheva-Barsova
Faculty of Medicine, Department of Otorhinolaryngology, Cyril and Methodius University of
Skopje, Skopje, Republic of North Macedonia
© The Author(s), under exclusive license to Springer Nature
Switzerland AG 2024
H. Yüksel et al. (eds.), Pediatric Airway Diseases, Comprehensive ENT,
https://doi.org/10.1007/978-3-031-74853-0_34
437

438
Animal sources such as house dust, mites, pollen, cats and dogs, molds, and food
allergies, which are increasingly common, can be stated as these allergens [7].
M. C. Gökgöz et al.
34.2 Epidemiology
34.2.1 Prevalence
In recent years, there has been an increase in the majority of allergic rhinitis, asthma,
and atopic dermatitis. Environmental factors and lifestyle changes, diet changes,
increased hygiene hypothesis, increased exposure to indoor antigens, and environmental toxins can be expressed as the reason for this increase [8]. In a study conducted in developed countries, the prevalence of allergic rhinitis has reached up to
50% [9]. Although the prevalence is higher in high-income countries, symptom
scores reach higher levels in low- and middle-income countries [10]. Based on the
study conducted by The International Study of Asthma and Allergies in Childhood
in 98 countries and nearly 1.2 million children, the prevalence of allergic rhinitis is
8.5% in the 6–7 age group, while it rises to 14.6% in the 13–14 age group [11].
Regarding the prevalence of comorbid diseases, 20% of patients with asthma have
allergic rhinitis, while 40% of patients diagnosed with allergic rhinitis have
asthma [4].
34.2.2 Risk factors
Risk factors include family history, being male, being the rst child in the family,
maternal and paternal smoking, systemic antibiotic use at an early age, especially
indoor allergen exposure, increased hygiene status, having a serum IgE level of
>100IU/mL before 6years of age and the presence of allergen-specic IgE [8, 12].
In addition to that, exposure to farm animals, air pollution, and high-intensity sports
in adolescence can be added to the risk factors [13]. The same risk factors often
apply to asthma and atopic dermatitis.
34.3 Etiology andPathogenesis
34.3.1 Classical Pathway
Allergen-specic IgE antibodies, formed due to previous allergen exposure, lead to
the release of inammatory mediators by binding to mast cells located in the respiratory mucosa and basophils in the circulation. Histamine, leukotrienes, and prostaglandins released by mast cells cause clinical ndings by secreting platelet-activating
factors and bradykinin. Moreover, the release of eosinophilic mediators increases
inammation. While the early phase occurs 15–30min following allergen exposure,
the late response peaks after 6–12h.

34 Pediatric Allergic Rhinitis: Otolaryngology Perspective
439
34.3.2 Nasal Pathway
The nasal mucosa is the rst line of defense against respiratory bacteria, viruses,
and allergens. It achieves this line of protection through the immune response to the
deteriorations in the mucosal integrity; in this way, it initiates protective inammatory processes. The allergic immune reaction begins sensitizing when an allergen
substance is encountered without an immune clinical response. At this stage, dendritic cells in the nasal mucosa present the allergen to CD+ T cells. Subsequently,
CD+ T cells transform into allergen-specic type 2 T helper cells. B cells are transformed into allergen-specic IgE-producing plasma cells upon B cell activation.
Circulating IgE binds with high afnity to its receptors located on mast cells and
basophils. This process ends with allergen-specic T helper cells and B cells forming memory against this allergen.
In the pathophysiology of allergic rhinitis, respiratory allergens disrupt epithelial
integrity through protease enzyme activity, stimulate previously sensitive receptors,
and result in an allergen-specic response. The immune response is initiated by
releasing IL (Interleukin)-33, thymic stromal lymphopoietin (TSLP), or IL-25 [14].
These, in turn, cause the release of IL-5, IL-13, and IL-4 cytokines, which provide
IgE-mediated immune response and mucosal inammation. It is considered that
pollutants, irritants, and infectious agents (Staphylococcus aureus or viruses) could
impact this pathway [15]. S. aureus is responsible for producing enterotoxins with
superantigenic properties and is a frequently observed bacterium in the respiratory
tract. Immune response to superantigens can be seen in both B and T cells. In the
presence of S. aureus in the nasal cavity in patients with allergic rhinitis, allergic
symptoms may be felt more severely with superantigens [16].
34.4 Diagnosis, Physical Examination, andDiagnostic Tests
34.4.1 Diagnosis andHistory
Patient history, physical examination, and allergy tests are primary in diagnosing
allergic rhinitis. In the diagnosis of allergic rhinitis, as in every disease, the account
to be taken from the patient in the pediatric age group and their parent is crucial in
making the correct diagnosis and for patient management. There are issues to be
considered in the history and physical examination when diagnosing rhinitis, determining its type, differentiating accompanying pathologies, and other diagnoses
[17, 18].
Before the physical examination, the physician should also shed light on the points
related to rhinitis, which might be overlooked by the parent, by asking various queries.
The patient’s age, since when the disease has been present, its frequency, duration,
and seasonal characteristics, whether it continues throughout the year, the presence of
exacerbations, whether there is a condition that causes the symptoms to occur, the
impact of environmental factors originating from home or school, the presence of
symptoms accompanying nasal symptoms, daily activities, school performance, sleep

440
M. C. Gökgöz et al.
patterns, whether it affects the patient’s and his parent’s quality of life, and the presence of family history should be questioned. If any, the patient’s previous allergy tests,
diagnostic tests, imaging tests, the company of medications or other treatments
received, and the history of surgery should be questioned [19] (Table34.1).
34.4.2 Physical Examination
In the physical examination to be performed by an otolaryngologist, particularly,
detection and differentiation of the accompanying diseases are of great importance.
During the inspection, “allergic salute- transverse external crease,” “Dennie-Morgan
lines,” allergic shiners (dark eye shadows, reecting venous pooling in the lid vessels.), and frequent throat clearing movements, which are indicators of postnasal discharge, can be noticed. Another critical point to be evaluated during the inspection is
the open-mouth breathing pattern due to chronic nasal obstruction, elongated facial
appearance (adenoid facies), and accompanying dental malocclusion problems. A
complete ear, nose, oropharynx, oral cavity, and neck examination should be performed in the physical examination. In the ear examination, dullness or retraction of
the tympanic membrane, air-uid levels as a result of Eustachian dysfunction due to
allergic rhinitis, presence of serous otitis, and accompanying hearing loss should be
evaluated via audiometric tests and tympanometry. In the nasal examination, the presence and consistency of nasal discharge in anterior rhinoscopy, septum pathologies,
hypertrophies of the inferior turbinate and middle turbinate, pallor or a pale bluish hue
accompanied by mucosal edema, the presence of nasal polyps or foreign bodies,
crusting, and perforation can be evaluated. Albeit anterior rhinoscopy is a simple procedure to perform, patient and parent compliance is signicant for nasal endoscopy. It
is more challenging to apply in children younger than 2years old. The process can be
performed via rigid or exible 2.7–4 mm endoscopes. Local anesthetic and
Table 34.1 Clinical symptoms and relation with age groups in pediatric ages
Age groups
Pre-
Clinical symptoms
Rhinorrhea (watery, discolored) x X X
Pruritis/itching (allergic salute, allergic crease, itchy mouth
and throat)
Sneezing x X X
Nasal congestion x X X
Cough (with/without asthma) >2years X X
Eustachian dysfunction (due to nasal congestion) x X
Sleep problems (due to nasal obstruction) >2years x X
Rhinosinusitis related symptoms (Nasal congestion, purulent
nasal discharge, cough, facial pain and pressure, mucosal
edema, polyp)
Prolonged respiratory tract infections >2years x X
Irritability, poor school performance x x
school School Adolescent
x X X
x X
Соседние файлы в папке Библиотека им академика М.И. Перельмана
